Nishi A[au] - Search Results

Year	Number of Results
1961	2
1962	3
1963	2
1964	1
1965	4
1966	1
1969	4
1971	2
1973	1
1975	1
1979	2
1981	1
1983	2
1984	3
1985	2
1987	1
1988	1
1989	1
1990	1
1991	2
1992	3
1993	7
1994	3
1995	6
1996	5
1997	3
1998	3
1999	7
2000	4
2001	6
2002	3
2003	6
2004	8
2005	7
2006	6
2007	8
2008	11
2009	6
2010	7
2011	13
2012	17
2013	13
2014	15
2015	22
2016	20
2017	7
2018	11
2019	13
2020	16
2021	26
2022	7

1

Development of an Individualized Occupational Therapy Programme and its Effects on the Neurocognition, Symptoms and Social Functioning of Patients with Schizophrenia.

Shimada T, Nishi A, Yoshida T, Tanaka S, Kobayashi M. Shimada T, et al. Among authors: nishi a. Occup Ther Int. 2016 Dec;23(4):425-435. doi: 10.1002/oti.1445. Epub 2016 Oct 17. Occup Ther Int. 2016. PMID: 27748565 Free article. Clinical Trial.

2

Mindfulness Meditation Activates Altruism.

Iwamoto SK, Alexander M, Torres M, Irwin MR, Christakis NA, Nishi A. Iwamoto SK, et al. Among authors: nishi a. Sci Rep. 2020 Apr 16;10(1):6511. doi: 10.1038/s41598-020-62652-1. Sci Rep. 2020. PMID: 32300129 Free PMC article.

3

LimeMap: a comprehensive map of lipid mediator metabolic pathways.

Nishi A, Ohbuchi K, Kaifuchi N, Shimobori C, Kushida H, Yamamoto M, Kita Y, Tokuoka SM, Yachie A, Matsuoka Y, Kitano H. Nishi A, et al. NPJ Syst Biol Appl. 2021 Jan 27;7(1):6. doi: 10.1038/s41540-020-00163-5. NPJ Syst Biol Appl. 2021. PMID: 33504811 Free PMC article.

4

Hemoglobin E, malaria and natural selection.

Ha J, Martinson R, Iwamoto SK, Nishi A. Ha J, et al. Among authors: nishi a. Evol Med Public Health. 2019 Dec 13;2019(1):232-241. doi: 10.1093/emph/eoz034. eCollection 2019. Evol Med Public Health. 2019. PMID: 31890210 Free PMC article. Review.

5

[Pathogenic and Compensatory Mechanisms in Epidermis of Sphingomyelin Synthase 2-Deficient Mice].

Sakai S, Makino A, Nishi A, Ichikawa T, Yamashita T, Taniguchi M, Tokudome Y, Hirabayashi Y, Akiyama M, Crumrine D, Uchida Y, Elias PM, Tsuchida T, Hamanaka S. Sakai S, et al. Among authors: nishi a. Skin Pharmacol Physiol. 2021;34(5):246-252. doi: 10.1159/000515608. Epub 2021 Apr 29. Skin Pharmacol Physiol. 2021. PMID: 33915532 Free PMC article.

6

Lifecourse epidemiology and molecular pathological epidemiology.

Nishi A, Kawachi I, Koenen KC, Wu K, Nishihara R, Ogino S. Nishi A, et al. Am J Prev Med. 2015 Jan;48(1):116-9. doi: 10.1016/j.amepre.2014.09.031. Am J Prev Med. 2015. PMID: 25528613 Free PMC article. Review. No abstract available.

7

DARPP-32: an integrator of neurotransmission.

Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. Svenningsson P, et al. Among authors: nishi a. Annu Rev Pharmacol Toxicol. 2004;44:269-96. doi: 10.1146/annurev.pharmtox.44.101802.121415. Annu Rev Pharmacol Toxicol. 2004. PMID: 14744247 Review.

8

The role of DARPP-32 in the actions of drugs of abuse.

Nairn AC, Svenningsson P, Nishi A, Fisone G, Girault JA, Greengard P. Nairn AC, et al. Among authors: nishi a. Neuropharmacology. 2004;47 Suppl 1:14-23. doi: 10.1016/j.neuropharm.2004.05.010. Neuropharmacology. 2004. PMID: 15464122 Review.

9

Revisiting the county/city-level event risk assessment during the COVID-19 pandemic.

Nishi A, Lee LF, Tsuji H, Takasaki Y, Young SD. Nishi A, et al. J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2020.12.031. Epub 2021 Jan 3. J Infect. 2021. PMID: 33406395 Free PMC article. No abstract available.

10

Contribution of HLA-B*51:01 and -A*26:01 to Behçet's disease and their clinical association in Thai patients.

Louthrenoo W, Kasitanon N, Pathanapitoon K, Wangkaew S, Kuwata S, Nishi A, Kaburaki T, Tanaka R, Takeuchi F. Louthrenoo W, et al. Among authors: nishi a. Int J Rheum Dis. 2020 Feb;23(2):247-255. doi: 10.1111/1756-185X.13785. Epub 2020 Jan 15. Int J Rheum Dis. 2020. PMID: 31944588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results